SEC Form D · filed January 18, 2017
Evelo Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
David P. Perry · Cambridge, MADirectorMark P. Bodmer, Ph.D · Cambridge, MAExecBalkrishan (Simba) A. Gill, Ph.D · Cambridge, MAExec · DirectorDavid A. Berry, M.D., Ph.D · Cambridge, MADirectorNoubar B. Afeyan, Ph.D · Cambridge, MADirectorWilliam P. Devaul · Cambridge, MAExecMark A. Pruzanski · Cambridge, MADirectorMarc W. Duncan · Houston, TXExecDharmesh P. Singh · Redmond, WADirectorJeffrey W. Harder · Houston, TXDirectorTed P. Wang · Redmond, WADirectorAalok W. Shah · Houston, TXExec · DirectorDerrick W. Hale · Houston, TXExecJackie P. Papkoff · Cambridge, MAExecDerek P. Adams · Cambridge, MAExecHassan Mahmoud · Secaucus, NJExec · DirectorAbed Elsamna · Secaucus, NJExecMayTech Capital Management LLC · New York, NYExecMayTech Partners LLC · New York, NYDirectorBenjamin Bixby · Watertown, MADirectorJesse Sielaff · Watertown, MADirectorJackie P. Papkoff · Cambridge, MAExecDerek P. Adams · Cambridge, MAExecMark A. Pruzanski · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗